FDA simplifies Covid-19 bivalent vaccination process ahead of June adcomm

Paul Schloesser

Associate Editor

The FDA is modifying the emergency use authorization for Moderna and Pfizer/BioNTech’s Covid-19 vaccines by removing the two-dose primary series (except for children) and the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA simplifies Covid-19 bivalent vaccination process ahead of June adcomm

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

CBER's deputy director departs as staff shakeup continues

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

FDA sim­pli­fies Covid-19 bi­va­lent vac­ci­na­tion process ahead of June ad­comm

Associate Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

FDA simplifies Covid-19 bivalent vaccination process ahead of June adcomm